Cumberland Pharmaceuticals
CPIX • NASDAQ
Cumberland Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO A. J. Kazimi, with a market cap of $46.5M.
Market Cap$46.5M
Employees91.0
CEOA. J. Kazimi
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
CPI
Cumberland Pharmaceuticals FAQ
Common questions about Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 5, 2026.
Cumberland Pharmaceuticals has approximately 91 employees.